Moneycontrol PRO
Open App

Buy Gland Pharma: target of Rs 4400: Sharekhan

Sharekhan is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 4400 in its research report dated November 26, 2021.

November 30, 2021 / 04:31 PM IST
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Gland Pharma

Gland plans to increase the share of revenues from RoW markets to 40% (21% Currently) over next 3-4 yea led by a strong growth from foray in China markets and increasing penetration in existing Row markets. Well dive ified product portfolio, strong product pipeline and strengthening of the base business in the US would drive the Core market segment performance. Vaccine manufacturing opportunity has taken Gland closer to its long term strategy of entering the lucrative biosimilar CDMO space.


We re-iterate Buy recommendation on Gland Pharma (Gland) with an unchanged PT of 4,400

For all recommendations report, click here


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Nov 30, 2021 04:31 pm
ISO 27001 - BSI Assurance Mark